Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter StudyJingwen Ai, Ci Qu, Ying Guo et al.|Clinical Gastroenterology and Hepatology|2021Cited by 73
Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective studyXiaolong Qi, Wenhong Zhang, Jitao Wang et al.|Journal of Medical Virology|2022Cited by 12